Arcus Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $1.10B
Liabilities Breakdown FY2023
Total Liabilities: $633.0M
Asset Breakdown
Total Assets: $1.10B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $127.0M | 11.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $51.0M | 4.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $917.0M | 83.7% |
Liabilities Breakdown
Total Liabilities: $633.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $17.0M | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $616.0M | 97.3% |